Stereotactic ablative radiotherapy (SABR), historically known as stereotactic body radiation therapy (SBRT), has rapidly developed into an important tool radiation oncologists use in the treatment of lung cancers. The indications for treatment of medically inoperable lung cancers have become well ...
Stereotactic ablative body radiotherapy (SABR) represents a technological breakthrough in radiotherapy technique, with proven benefits to patients in terms of improved tumour control and overall survival. The key components of SABR are described. The current evidence base for SABR for the treatment of ...
Stereotactic ablative radiotherapy (SABR) has emerged standardtreatment peripherallylocated medically inoperable stage non-smallcell lung cancer (NSCLC) (1-5). SABR,local control primarytumors greaterthan 90% tumorsup regionallymph node recurrence within low(5% 10%).Distant metastasis remains dominant...
We thank both Liyang Jiang and colleagues and Elif Hindié for their thoughtful comments on the trial of stereotactic ablative radiotherapy with immunotherapy (I-SABR).1 Biomarker-based immunotherapy has become the standard of care in metastatic non-small-cell lung cancer (NSCLC). Recently, phase ...
Image-guided stereotactic ablative radiotherapy (SABR; also called stereotactic body radiotherapy or radiosurgery) has become a standard treatment for medically inoperable peripherally located stage I non–small-cell lung cancer (NSCLC) and can achieve local control rates in excess of 90%. However, ...
The result of this recent research means that bevacizumab has little, if...doi:10.1016/S0169-5002(14)70172-2Ramasamy, S.Musunuru, H.Sangha, V.Flatley, M.Spencer, K.Turner, R.N.Stuart, R.Clarke, K.L.Needham, A.Lilley, J.Elsevier Ireland LtdLung Cancer...
摘要原文 To update the 2012 UK stereotacticablative radiotherapy (SABR) Consortium survey and assess the development of SABR services across the UK over the past 6 years. Use the results to share practice and continue to drive forward technique development, aid standardization and by highlighting iss...
Stereotactic ablative radiotherapy (SABR) is a standard-of-care for medically-inoperable-early-stage non-small cell lung cancer (NSCLC). One third of patients progress and chemotherapy is rarely used in this population. We questioned if addition of the immune-checkpoint-inhibitor (ICI) atezolizumab...
lung resections in patients who develop a local recurrence following stereotactic ablative radiotherapy (SABR), is limited. We describe our experience with salvage surgery in nine patients who developed a local recurrence following SABR for early stage non-small cell lung cancer (NSCLC). Patients ...